1. Qin LX, Tang ZY. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol, 2002, 8: 385–392.
2. Chen XM, Luo PF, Lin HH, et al. Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma. Chin J Cancer (Chinese), 2004, 23: 829–832.
3. Yang BH. The Diagnosing and staging national standards for hepatocellular carcinoma. Chin J Hepatol (Chinese), 2001, 9: 324.
4. Hao MZ, Chen Qiang, Ye YB, et al. Transcatheter arterial chemoembolization combined with cytokine induced killers in treatment of hepatocellular carcinoma. Chin J Cancer Biother (Chinese), 2006, 13: 303–304.
5. Hao MZ, Lin HL, Chen Qiang, et al. Efficacy of transcatheter arterial chemoembolization combined thalidomide on hepatocellular carcinoma: a controlled randomized trial. Chin J Cancer (Chinese), 2007, 26: 861–865.